Thomas Von Koch
CIK: 0001938915
Transaction Breakdown
Open Market Buys (P)1 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DMAC
DiaMedica Therapeutics Inc.
10% Owner
Discretionary Trading P&L
Holdings
About Von Koch Thomas
Von Koch Thomas (SEC CIK 0001938915) files insider reports with the SEC as 10% Owner of DiaMedica Therapeutics Inc. (DMAC).
Signal8 holds 1 ownership filing by Von Koch Thomas, a Form 4, filed on Jul 25, 2025. Those filings report 1 transaction, the latest on Jul 23, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Von Koch Thomas's filings is in STOCKHOLM, V7.
Recent filings by Von Koch Thomas
- Jul 23, 2025: Open-market purchase of DMAC shares (Form 4, code P).
Other insiders filing for DiaMedica Therapeutics Inc. (DMAC)
- Pauls Dietrich John, President & CEO
- Giuffre Randall Michael, Director
- Kuntz Richard, Director
- O'Connor Daniel J., Director
- Lewis Tanya, Director
- Semba Charles Pauling, Director